|
Age, Mean (SD)
|
75.3 (7.6)
|
74.9 (7.0)
|
|
Gender, N (%)
|
|
Male
|
672,755 (41.4%)
|
44,740 (58.6%)
|
|
Female
|
950,549 (58.6%)
|
31,569 (41.4%)
|
|
Race, N (%)
|
|
White
|
1,403,749 (86.5%)
|
63,434 (83.1%)
|
|
Black
|
128,197 (7.9%)
|
8585 (11.3%)
|
|
Others
|
91,358 (5.6%)
|
4290 (5.6%)
|
|
Charlson-Romano comorbidity score2, Mean (SD)
|
1.5 (2.5)
|
2.0 (2.4)
|
|
Charlson-Romano comorbidity score, N (%)
|
|
0
|
883,689 (54.4%)
|
28,407 (37.2%)
|
|
1
|
163,358 (10.1%)
|
10,658 (14.0%)
|
|
≥ 2
|
576,257 (35.5%)
|
37,246 (48.8%)
|
|
Select Charlson-Romano comorbidities
|
|
Myocardial Infarction
|
59,625 (3.7%)
|
4450 (5.8%)
|
|
Heart Failure
|
172,489 (10.6%)
|
14,630 (19.2%)
|
|
Peripheral vascular disease
|
148,616 (9.2%)
|
10,082 (13.2%)
|
|
Cerebrovascular disease
|
152,599 (9.4%)
|
9046 (11.9%)
|
|
Dementia
|
74,277 (4.6%)
|
1926 (2.5%)
|
|
Chronic pulmonary disease
|
245,086 (15.1%)
|
15,297 (20.0%)
|
|
Connective tissue disease
|
43,359 (2.7%)
|
3063 (4.0%)
|
|
Peptic ulcer disease
|
29,277 (1.8%)
|
1923 (2.5%)
|
|
Mild liver disease
|
7583 (0.5%)
|
533 (0.7%)
|
|
Diabetes
|
280,819 (17.3%)
|
21,459 (28.1%)
|
|
Diabetes with end organ damage
|
77,421 (4.8%)
|
5906 (7.7%)
|
|
Hemiplegia
|
13,144 (0.8%)
|
634 (0.8%)
|
|
Hypertension
|
752,833 (46.4%)
|
53,555 (70.2%)
|
|
Hyperlipidemia
|
545,421 (33.6%)
|
37,898 (49.7%)
|
|
Coronary artery disease
|
267,429 (16.5%)
|
21,123 (27.7%)
|
|
Obesity
|
30,761 (1.9%)
|
3285 (4.3%)
|
